Resveratrol promotes Rac activity in breast cancer cells by expressing dominant-negative Cdc42 or Rac and preserving filopodia responsiveness, so Rac and Cdc42 may regulate actin cytoskeleton signaling differently at low and high concentrations. This evidence concerns the gene AKT1 and breast carcinoma.